XTL BIOPHARMACEUTICALS LTD | CIK:0001023549 | 3

  • Filed: 3/15/2018
  • Entity registrant name: XTL BIOPHARMACEUTICALS LTD (CIK: 0001023549)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/0001213900-18-003028-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/xtlb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001023549
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory

    NOTE 17:RESEARCH AND DEVELOPMENT EXPENSES

     

      Year ended December 31, 
      2017  2016  2015 
      U.S. dollars in thousands 
              
    Fees related to service providers  51   145   121 
    Expenses relating to options to employees and non-employees  2   7   8 
    Professional consulting  -   109   360 
    Lab materials  2   134   75 
    Other  (12)  48   14 
                 
       43   443   578